Melanoma: An immunotherapy journey from bench to bedside.

Cancer Treat Res

Centre for Drug Repurposing and Medicines Research, University of Newcastle and Hunter Medical Research Institute, University Dr, Callaghan, NSW, 2308, Australia.

Published: May 2022

Melanoma gave science a window into the role immune evasion plays in the development of malignancy. The entire spectrum of immune focused anti-cancer therapies has been subjected to clinical trials in this disease, with limited success until the immune checkpoint blockade era. That revolution launched first in melanoma, heralded a landscape change throughout cancer that continues to reverberate today.

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-030-96376-7_2DOI Listing

Publication Analysis

Top Keywords

melanoma immunotherapy journey
4
immunotherapy journey bench
4
bench bedside
4
bedside melanoma
4
melanoma science
4
science window
4
window role
4
role immune
4
immune evasion
4
evasion plays
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!